Treatment of dyslipidemia and cardiovascular outcomes: the journey so far--is this the end for statins?
about
Predicted impact of lipid lowering therapy on cardiovascular and economic outcomes of Swedish atherosclerotic cardiovascular disease guideline.Statins decrease leptin expression in human white adipocytes.Metabolic distress in lipid & one carbon metabolic pathway through low vitamin B-12: a population based study from North India.Does Adjuvant Treatment With Ginkgo Biloba to Statins Have Additional Benefits in Patients With Dyslipidemia?
P2860
Treatment of dyslipidemia and cardiovascular outcomes: the journey so far--is this the end for statins?
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Treatment of dyslipidemia and ...... --is this the end for statins?
@en
type
label
Treatment of dyslipidemia and ...... --is this the end for statins?
@en
prefLabel
Treatment of dyslipidemia and ...... --is this the end for statins?
@en
P2860
P50
P356
P1476
Treatment of dyslipidemia and ...... --is this the end for statins?
@en
P2093
A M Tonkin
P2860
P2888
P304
P356
10.1038/CLPT.2014.86
P407
P577
2014-04-11T00:00:00Z
P5875
P6179
1042831233